Biogen's statement re. Scottish decision on nusinersen availability
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Australia will allocate 240 million Australian dollars to fund the break-through Spinraza treatment for those with spinal muscular atrophy.
Below is an outline of the regulatory appraisal process of Spinraza in England and Wales.
TreatSMA is looking for a trustee!
A new Standard of Care in spinal muscular atrophy has been published.
Google deprives TreatSMA of access to email and data again
TreatSMA would like to thank the Family of little fighter George for raising £2,750 in support of TreatSMA.